文献速递免疫规划传染病防控与疫情报告

优化基于919株的牛流行热病毒疫苗(Ultravac®,Zoetis™)方案:剂量依赖性效果与长期免疫评价

Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac®, Zoetis™): Evaluation of dose-dependent effectiveness and long-term immunity.
PubMed 文献 · Vaccine · 2024-11-22

该回顾性队列研究纳入850头牛(7个牛群),分析不同接种方案对牛流行热疫苗效果的影响,并对71头牛进行血清学调查以检测中和抗体持久性。结果显示,与零剂次相比,四剂次疫苗效果为82%(p<0.001),三剂次为66%(p<0.026),两剂次为39%(p=0.3);四剂次几何平均滴度最高(4.45,95%CI 3.99–4.91)。作者建议犊牛4–6月龄接种两剂(间隔1个月),6–12个月后加强第三甚至第四剂。

要点

  • 四剂次疫苗效果82%(p<0.001),三剂次66%(p<0.026),两剂次39%(p=0.3),均与零剂次比较。
  • 四剂次几何平均滴度最高(4.45,95%CI 3.99–4.91),三剂次3.53(95%CI 3.08–3.98),两剂次2.17(95%CI 1.77–2.57)。
  • 作者建议犊牛4–6月龄接种两剂(间隔1个月),6–12个月后加强第三甚至第四剂,最好在高风险季节前。

核心结论

  • 与零剂次相比,四剂次和三剂次方案可提高疫苗效果,两剂次方案效果未达统计学显著(39%,p=0.3)。
  • 四剂次方案诱导的几何平均滴度最高,三剂次次之,两剂次最低。
  • 作者建议犊牛4–6月龄接种两剂(间隔1个月),6–12个月后加强第三甚至第四剂,最好在高风险季节前。

研究设计与样本

  • 回顾性队列研究,纳入850头牛(7个牛群),分析不同接种方案对疫苗效果的影响。
  • 血清学调查纳入71头牛,检测牛流行热病毒特异性血清中和抗体持久性。
  • 采用经验证的精准奶牛监测技术定量识别产奶量下降以诊断牛流行热,采用生存分析评估疫苗剂量效果,拟合Cox回归混合效应模型(COXME)。

主要发现

  • 与零剂次相比,四剂次疫苗效果为82%(p<0.001),三剂次为66%(p<0.026),两剂次为39%(p=0.3)。
  • 四剂次几何平均滴度为4.45(95%CI 3.99–4.91),三剂次为3.53(95%CI 3.08–3.98),两剂次为2.17(95%CI 1.77–2.57)。

临床怎么用

  • 作者建议犊牛4–6月龄接种两剂,间隔1个月。
  • 作者建议在6–12个月后加强第三甚至第四剂,最好在高风险季节前接种。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bovine Ephemeral Fever (BEF) is an arthropod-borne virus (arbovirus) that presents a significant challenge to the cattle industry due to its economic impact, primarily through the loss of milk production in dairy cows. Vaccination is the predominant strategy for managing the disease. We recently showed a vaccine effectiveness (VE) of 60 % of a vaccine based on the Australian 919 BEFV isolate, with a natural challenge occurring shortly after the administration of the second dose of the vaccine. Still, there is a lack of data regarding the duration of protective immunity after vaccination and its potential enhancement after the administration of three and four vaccine doses. To answer these questions we conducted a retrospective cohort study of 850 cows (7 herds), analyzing the influence of different vaccination regimens on VE and a serosurvey of 71 cows to test the longevity of BEFV-specific serum-neutralizing antibodies (SNAb). We adopted a quantitative methodology for BEF diagnosis with the use of commercially validated precision dairy monitoring technologies for milk reduction identification. Survival analysis was used to analyze the vaccine dose effectiveness. A Cox regression mixed-effect model (COXME) was fitted to the data. The analysis demonstrated the following VE compared to zero vaccine doses: 82 % (p-value<0.001) for four doses, 66 % (p-value<0.026) for three doses and 39 % (p-value = 0.3) for two doses. Corroborating with the VE results, the four-dose regimen exhibited the highest geometric mean titer (GMT) value (4.45, CI95% = 3.99, 4.91), followed by the three-dose regimen (3.53, CI95% = 3.08,3.98), and the two-dose regimen (2.17, CI95% = 1.77,2.57). In light of these findings, we recommend vaccinating calves as early as four to six months old with two doses spaced one month apart, followed by a third and even fourth dose administered between six to 12 months later, ideally close to the onset of the high-risk season.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gleser D, Cohen M, Kenigswald G, et al. Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac®, Zoetis™): Evaluation of dose-dependent effectiveness and long-term immunity. Vaccine. 2024. PMID: 39579670. doi:10.1016/j.vaccine.2024.126531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。